Skip to main content

Day: March 20, 2020

Sanoma täydentää 25.3. pidettävään yhtiökokoukseen liittyviä ennaltaehkäiseviä toimia; vaadittu enemmistö kannattaa kaikkia yhtiökokoukselle tehtyjä ehdotuksia

Sanoma Oyj, Pörssitiedote, 20.3.2020 klo 13:45Sanoma täydentää 25.3. pidettävään yhtiökokoukseen liittyviä ennaltaehkäiseviä toimia; vaadittu enemmistö kannattaa kaikkia yhtiökokoukselle tehtyjä ehdotuksiaSanoma Oyj järjestää keskiviikkona 25.3.2020 klo 14 pidettävän varsinaisen yhtiökokouksensa koronavirusepidemian torjumiseksi annettuja viranomaismääräyksiä noudattaen. Ilmoittautumisaika kokoukseen on päättynyt. Tähän mennessä saatujen valtakirjojen ja äänestysohjeiden perusteella voidaan todeta, että lain vaatima enemmistö kannattaa jokaista kokouskutsun mukaista yhtiökokoukselle tehtyä esitystä.Viranomaismääräysten noudattamiseksi kokouspaikalla olevien osallistujien määrää joudutaan rajoittamaan, jotta yhdessä huoneessa samaan aikaan olevien henkilöiden määrä on enimmillään kymmeneen. Osakkeenomistajia pyydetään omalta osaltaan noudattamaan...

Continue reading

Verona Pharma plc: Issue of Equity and Total Voting Rights

LONDON, March 20, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces that it yesterday issued 887,080 Ordinary Shares of 5 pence each (the “New Ordinary Shares”) following the vesting of restricted stock units held by former employees in the Company, Jan-Anders Karlsson and Piers Morgan.Application will be made to the London Stock Exchange for the New Ordinary Shares to be admitted to trading on AIM, with dealings expected to commence on March 26, 2020 (“Admission”).Total voting rightsFollowing Admission, the Company will have a total of 106,213,718 Ordinary Shares in issue each carrying one voting right. The Company does not hold any Ordinary Shares in Treasury....

Continue reading

Internationally Renowned Neurologist Dr. Juan Fortea Joins AC Immune’s Clinical Advisory Board

LAUSANNE, Switzerland, March 20, 2020 (GLOBE NEWSWIRE) — AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced Dr. Juan Fortea, an internationally renowned neurologist with a specific focus in the emerging field of Down syndrome-related Alzheimer’s disease, is to join the Company’s Clinical Advisory Board (CAB).Dr Fortea combines his research and clinical activities at the Hospital of Sant Pau in Barcelona and the Catalan Foundation for Down Syndrome in Barcelona, Spain, where he leads the neuroimaging laboratory and directs the Alzheimer’s Disease and Down Syndrome Unit. He has extensive experience in clinical practice and in medical research, with a focus on the early diagnosis of neurodegenerative diseases, Alzheimer’s...

Continue reading

Tauriga Sciences, Inc. Firmly on Schedule to Launch its Tauri-Gum Product Line in Partnership with Erewhon Market – First Half of April 2020

All of the Tauri-Gum™ Flavors (Mint, Blood Orange, Pomegranate) will be Available at Each of the 5 Erewhon Market Locations (Calabasas, Santa Monica, Venice, Pacific Palisades, and Los Angeles)LOS ANGELES, CALIFORNIA, March 20, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced that it is firmly on track to launch its Tauri-Gum™ product line – in partnership – with Erewhon Market (“Erewhon”), during the first half of April 2020.  The Company is planning to formally launch with Erewhon on April 1, 2020, with its Tauri-Gum™ product line being available...

Continue reading

SATO Corporation´s Annual General Meeting on 1 April 2020 has been cancelled due to coronavirus status

SATO Corporation, Press release 20 March 2020 at 1:10 pmSATO Corporation’s Annual General Meeting summoned, on 1 April 2020, has been cancelled due to the pending coronavirus status. The Government of Finland has decided on restrictions, which include the number of people in events and travelling embargo.SATO Corporation´s Board of Directors will make the decision to summon the meeting at a later stage. SATO wants to ensure that participating in the meeting is safe both for its shareholders and SATO’s employees. For more information please contact:SATO Corporation, Katri Innanen, VP, General Counsel, tel. +358 400 678 898www.sato.fiDISTRIBUTIONMain media, www.sato.fi SATO is one of Finland’s leading rental housing providers. SATO aims to offer a comprehensive choice of rental housing and an excellent customer experience. At year-end...

Continue reading

SATO Oyj:n yhtiökokous 1.4.2020 on peruutettu koronavirustilanteen vuoksi

SATO Oyj, Lehdistötiedote 20.3.2020 klo 13.10SATO Oyj:n koolle kutsuttu yhtiökokous 1.4.2020 peruutetaan koronaviruksen aiheuttaman tilanteen vuoksi. Suomen hallitus on päättänyt rajaustoimenpiteistä, joihin kuuluvat esimerkiksi tilaisuuksien osallistujamäärän rajoitukset sekä matkustuskielto.SATO Oyj:n hallitus päättää yhtiökokouksen koollekutsumisesta myöhemmin ilmoitettavana ajankohtana. SATO haluaa varmistaa, että osallistuminen kokoukseen on turvallista sekä sen osakkeenomistajille että SATOn henkilöstölle.Lisätietoja:SATO Oyj, Katri Innanen, lakiasiainjohtaja, p. 0400 678 898www.sato.fiKeskeiset tiedotusvälineet, www.sato.fiSATO Oyj on yksi Suomen johtavista vuokranantajista. SATOn tavoitteena on tarjota kattavat vuokra-asumisen vaihtoehdot ja erinomainen asiakaskokemus. SATOn omistuksessa oli vuoden 2019 lopussa yhteensä yli 26...

Continue reading

The Joint Chiropractic is an Essential Healthcare Service

– Commits to keeping clinics open when and where possible during the crisis –– Withdrawing financial and clinic opening guidance –SCOTTSDALE, Ariz., March 20, 2020 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, reiterated its Essential Healthcare Services statement and commitment to keeping its system of chiropractic locations open when and where it is possible.Relying on guidance from governmental agencies, national and state chiropractic associations and local health departments to direct its action, including the International Chiropractors Association, Federation of Chiropractic Licensing Boards, as well as Texas Chiropractic Association and the Texas Board of Chiropractic Examiners, The Joint Corp. views chiropractic care as an...

Continue reading

Pyxis Tankers Inc. Announces Financial Results for the Three Months and Year Ended December 31, 2019

Maroussi, Greece, March 20, 2020 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), (the “Company” or “Pyxis Tankers”) a growth-oriented pure play product tanker company, today announced unaudited results for the three months and year ended December 31, 2019.SummaryFor the three months ended December 31, 2019, our Revenues, net were $7.3 million and our time charter equivalent revenues increased by $1.8 million, or 39.5%, to $6.2 million compared to the same period in 2018. For the quarter ended December 31, 2019, our net loss was $3.6 million, or a loss per share (basic and diluted) of $0.17, which was primarily due to a non-cash loss of $2.8 million (or $0.13/share) on the sale of our oldest vessel, the Pyxis Delta, that was recognized during the period. Our Adjusted EBITDA was $1.9 million, an increase of $1.7 million over the comparable...

Continue reading

Vedægter

Meddelelse nr. 5 – 2020 til Nasdaq Copenhagen   Den 20. marts 2020  VedtægterVedlagt fremsendes vedtægter som vedtaget på Brødrene A & O Johansen A/S’ generalforsamling den 20. marts 2020.Med venlig hilsenBRØDRENE A & O JOHANSEN A/SNiels A. JohansenAdm. direktør                                                                                                                                                                 Vedhæftet filVedtægter 2020

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.